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ABSTRACT
DIRECT MEASUREMENT OF FATTY ACID BINDING PROTEIN FROM RAT 
LIVER CYTOSOL
Name: Bathula Mridul
University of Dayton
Advisor: Dr. S.S. Singer
Rat liver fatty acid-binding protein (LFABP) is a 14-16 kDa cytosol protein which 
binds long chain free fatty acids and is believed to participate in intercellular movement 
and distribution of free fatty acids. My studies on LFABP are expected to lead to a direct 
assay to quantitate rat LFABP in cytosol. This new direct assay method is designed to
replace our present In-House Method (IHM) of FABP measurement which uses
Sephadex G-75 column chromatography and rose Bengal assay. This direct assay method 
will change the IHM from a day-long method to measure LFABP to a procedure that can 
be done in ~2 hours. The direct assay method is based upon a fluorescence enhancement
process where LFABP and rose Bengal interactions are exposed to emission of a 543 nm
laser to produce a fluorescence spectrum. The procedure was found specific for 
homogeneous LFABP (hLFABP), while potentially interfering components of cytosol,
hemoglobin, myoglobin, and serum albumin, do not fluoresce like hLFABP.
My experimental results indicate that cytosol can be directly used in the direct
assay method to quantitate FABP, and the presence of other potential contaminants in
iii
cytosol, along with FABP, do not interfere/alter the process to measure FABP. My 
research shows future promise in replacing the IHM and in the fields of medicine that
are attempting to understand and elucidate cures for lipid- related diseases. Since
LFABP takes part in dietary fatty acid transport from intestine to blood to liver, for 
bioenergy production and biosynthesis, any dysfunction of LFABP may cause or be 
associated with altered lipid uptake/metabolism. These studies can be extended in 
future to quantitate/study other FABPs like intestinal FABP (IFABP) and perhaps be 
helpful in making a biosensor for detecting FABP.
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CHAPTER 1
INTRODUCTION
1.1 Proteins and Chromatography
Proteins are macromolecules which are constructed from one or more unbranched
chains of amino acids. A typical protein contains 200-300 amino acids1. A very common 
technique that is used to separate biological molecules is called chromatography. 
Different chromatography procedures can be used to separate proteins into individual 
components2.
Some common chromatography methods used to separate proteins are partition 
chromatography, ion exchange chromatography, and molecular sieve or gel filtration 
chromatography2. In partition chromatography, a mixture of molecules is separated 
based upon their relative affinity for two immiscible phases (the mobile phase and the 
stationary phase) . Mobile phase is a buffer in which proteins are soluble and stationary 
phase is a column of beads containing pores.
Gel filtration chromatography which is used in our “In House Method” (IHM)3,4 
uses size differences to separates proteins. In gel filtration chromatography a protein 
solution is passed through a column that is packed with semi- permeable porous resin. 
The resin has a range of pore sizes that determine the size of protein that can be separated 
with the column . This is called the fractionation range or exclusion range of the resin.
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In our IHM a Sephadex G-753’4 porous matrix made of polysaccharide beads 
through which the proteins can diffuse is used. It has pores that exclude molecules larger 
than 80 kDa". The size of the pores in the matrix determines the rate at which proteins of
various sizes diffuse and pass through the beads. Molecules under 80 kDa can enter the 
pores of the beads, which impede the movement of such molecules. The excluded, larger 
molecules simply go around the beads. Because these larger proteins are unable to enter 
the pores they pass quickly through the column in the spaces between the resin beads and 
elute first. Very small proteins and other low molecular weight substances that are below 
the exclusion range of the resin enter all the pores in the resin, and move through the 
column very slowly because they must pass through the entire volume of the column. 
These molecules pass through the end of the chromatogram in a “totally included peak”2.
To separate a protein sample by gel filtration chromatography, the column must 
first be equilibrated with the desired buffer. This is accomplished by passing several 
column volumes of the buffer through it. Equilibration is an important step because the 
equilibration buffer is the buffer in which the protein sample will elute in a bioactive 
form. Next, the sample is loaded onto the column and allowed to enter the resin. Then 
more of the equilibration buffer is passed through the column to separate the sample and 
elute it from the column. Fractions (measured aliquots) are collected as the sample elutes 
from the column. Larger proteins elute in the early fractions and smaller proteins elute in 
subsequent fractions .
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FABPs, Their Roles and Significance
The proteins of interest here are fatty acid binding proteins (FABPs). FABPs are 
cytosolic proteins that non-covalently bind long-chain fatty acids (LCFA)5. Despite many 
years of research, the precise biological function(s) of FABPs remain unclear5,6. The 
proposed functions can be summarized as follows: FABPs are involved in facilitating the
uptake and intercellular transport of fatty acids, limiting ligand association with 
alternative binding sites within the cell, and modulating cell growth and differentiation5,6.
FABPs were originally classified as Z proteins , a pre-existing class originally 
found to be a binding protein for organic anions, fatty acids and aminoazodyes. Because 
of the anion-binding activity of rat Z protein, it was initially thought that a single protein 
was responsible for all FABP activity7. An early hypothesis was that intracellular FABPs 
bind fatty acids in the cytoplasm and thereby prevent their nonspecific detergent effects 
on disrupting membrane function. Intracellular FABP levels are in the 0.2 -0.4 mM range 
in the tissues active in fatty acid metabolism8.
Several different FABPs have been identified since then, each named after the 
tissue in which it was first discovered5,6. These include the heart, epidermis, adipose 
tissue, liver, and small intestine1. The amino acid sequences in FABPs exhibit 
considerable tissue specific variation9. FABPs are clam shell-shaped proteins consisting 
of two antiparallel p-pleated sheets of 5 strands apiece and 2 short a-helices forming the 
shell halves10. Rat liver FABPs are most extensively studied. They have a molecular mass 
of 14-16 kDa6.
The initial binding of the LCFA to a FABP occurs between the e-amino group on 
a FABP lysine residue and the carboxylate of the LCFA10,11. When lipids are digested,
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they are broken down into glycerol and fatty acids, and these fatty acids bind to FABP.
The term fatty acid identifies saturated and unsaturated monobasic carboxylic acids, and
several series of substituted acids having carbon skeletons identical with normal saturated
• -12acids exist . Fatty acids are important source of cellular energy and form the building 
blocks from which various cellular components are synthesized13. At least 60% of the 
long chain fatty acids found in the liver cytosol are bound to liver FABP12.
My research primarily concerns liver FABP (LFABP) in rats. LFABP is 
structurally and functionally different from the other FABP types6. LFABP binds two 
fatty acids per molecule, whereas the other FABP types have a single fatty acid binding 
site . LFABP may play a role as an intercellular acceptor of LCFA, by enhancing LCFA 
uptake and intercellular transport14. Several enzyme activities, especially enzymes 
involved in fatty acid metabolism, are stimulated by LFABP14. In contrast, intestinal fatty 
acid binding protein (IFABP) functions in the transfer of fatty acids from the intestine to 
the bloodstream 15. LFABP binds these free circulating fatty acids as they pass through 
the hepatic capillary bed and helps transfer them into liver cells for metabolism15. Thus, 
IFABP contributes to plasma fatty acid content while LFABP removes fatty acids from 
the bloodstream15,16.
Comparing the primary structure of the liver and intestinal FABPs indicates 
significant similarity as well as difference. In the amino-terminal domains there is a high 
degree of sequence homology, wherein 11 of the first 22 residues are identical12. The 
amino acid sequences exhibit considerable tissue specific variation9. Different FABP 
types in one species show amino acid sequence identities ranging from 20 to 70%17. 
Affinities, kinetics, and thermodynamics of FA interactions with FABP from different
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tissues are quite different, but these characteristics are quite similar for FABPs from the 
same tissue of different species9. For example, while A7/° for adipocyte, heart, intestine, 
and liver from oleate binding range from -7 to -12 kcal/mol, single Alanine substitution 
in intestine generates proteins with A/A ranging from -4 to -17 kcal/mol9.
LFABP is an abundant protein constituting 5% of the cytosolic mass in the liver, 
whereas IFABP constitutes 2.5% of the cytosolic mass in the intestine12. LFABP has the 
broadest substance specificity among FABPs studied and has an aqueous diffusion 
mediated lipid transfer mechanism which differs from other FABPs17,18. LFABP is a 
tumour cell marker in hepatic cell malignancies, colorectal and hepatic carcinomas. 
LFABP is useful for detection of liver damage during and after transplantation19,20. The 
primary function of soluble binding proteins such as FABP may be to enhance the 
diffusive fluxes of their ligands by reducing membrane binding6.
LFABP takes part in dietary fatty acid transport from intestine to blood to liver,
for bioenergy production and biosynthesis. Hence, dysfunction of either FABP or 
variation of the ratio of LFABP to IFABP3,4 may cause or be associated with altered lipid 
uptake/metabolism and lipid related diseases ’ such as diabetes, atherogenesis, and 
body fat increases often seen in old age. LFABP undergoes a conformational change 
upon fatty acid binding, changing its structure slightly as the fatty acid is integrated into 
the protein6. LFABP levels are known to be gender dependent, with females showing 
higher levels than males10. A low amount of LFABP relative to the amount of IFABP 
may correspond to a higher level of circulating fatty acids in the bloodstream, which 
could in turn contribute to lipid deposition in the blood vessels3,4. Atherosclerosis and 
hypertension may develop as a result3, 4. A significant difference of LFABP and IFABP
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level/ratio was seen in different rats of both genders in the previous research in our 
laboratory3,4. LFABP has been studied extensively, particularly in rats. Previous research 
shows that primary amino acid sequence of rat liver FABP is 82 % homologous to human 
liver FABP5 and that rat and human Z protein exhibited similar binding affinities for 
various bile acids. It was also shown that administration of different drugs like clofiberate 
to rats increases LFABP levels 3’4. It is thought that the increase in levels of FABP is due 
to retention of export proteins. LFABP is thought to covalently bond to the drugs, causing 
increase in levels of LFABP3,4. The specific mechanism for this process is not known.
1.2 In-House Method
The present in-house method (IHM) to measure fatty acid binding protein in rat 
liver at our laboratory was designed over ten years3,4 with several different steps. It is 
complex, labor-intensive and takes a whole day’s work (8 hours) to process liver and
intestine samples from one rat. The most recent form of the IHM uses molecular sieve
chromatography to separate a very complex mixture of proteins into simpler mixtures that 
allow assessment of the presence and content of LFABP in a test sample of liver cytosol. 
The IHM uses Sephadex G-75 polymer matrix in the chromatography column to separate 
FABP. The IHM requires 4 grams of tissue to be processed through a column
chromatogram followed by 3 different assays to measure/quantitate LFABP (see section
1.2). The IHM has been used to identify and compare to controls FABPs present and their 
levels during life cycle change and as consequences of drug administration3,4,21. The new 
method I am seeking to develop to quantitate LFABP by direct measurement of rose 
Bengal (RB) absorption in cytosol takes two hours to process and quantitate, using less
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then one gram of tissue. The method is based upon a fluorescence enhancement process 
in which the FABP-rose Bengal complex in a sample is exposed to emissions of a 543.5 
nm laser and produces a fluorescence spectrum. The new method uses the
spectrochemical perturbation caused by binding of LFABP to rose Bengal dye for direct
measurement of LFABP.
This direct assay method, when perfected, will change the IHM from a complex, 
labor-intensive, day long method to one that can be done in approximately two hours. I 
found the procedure to be specific for homogenous LFABP (hLFABP). The main 
potential interfering proteins in liver, hemoglobin, myoglobin and serum albumin, do not
fluoresce or alter data taken with hLFABP. In addition, examination of LFABP-
containing fractions from Sephadex G-75 shows that they contain about 90% of 
fluorescing material and the remainder of the fractions give about 10% as much 
fluorescence as seen with LFABP containing fractions. Several samples of cytosol that 
contain LFABP in known quantities were used in our new direct assay method and 
compared with Sephadex G-75 pool assay. It was seen that the enhancement of the 
emission peak was directly proportional to the amount of FABP present in the sample. 
The new assay method, when perfected, will facilitate uncovering FABP roles in health 
and disease, improving treatment of lipid related human diseases. This process will add to 
our ability to study FABPs and can further be used to study IFABP. This approach could 
possibly be extended to making a biosensor for detecting liver fatty acid binding proteins.
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CHAPTER 2
OBJECTIVES
The objective is to develop a new method to directly measure LFABP from cytosol.
My work seeks to:
• Show that rose Bengal absorption enhancement by new method is proportional to
LFABP concentration, with homogenous LFABP.
• Prove specificity of the LFABP effect by comparing it to hemoglobin, serum
albumin and myoglobin.
• Demonstrate that cytosol proteins other than FABP do not contribute to the FABP
effect.
• Show that direct FABP binding in cytosol gives results comparable to the data
obtained with the IHM.
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CHAPTER 3
MATERIALS AND METHODS
3.1 Materials
The following instruments and chemicals were used in preparation of cytosol 
from liver, separation of FABP, assays, and direct measurement of FABP.
Instruments
Beckman L5-65B ultracentrifuge (Beckman Coulter, Inc., Palo Alto, CA), 
homogenizer apparatus (Arthur H. Thomas, Philadelphia, PA), IEC Centra-B Plus low 
speed centrifuge (International Equipment Company, Needham Heights, MA), Mettler 
Toledo electronic balance Model # AG104 (Mettler Toledo, Inc., Columbus, OH), Milton 
Roy Spectronic Genesys 5 (Milton Roy USA, Ivyland, PA) and Genesys 8 (Spectronic 
Instruments, Madison, WI) spectrophotometers, YSI-2700 Select Biochemistry Analyzer 
(YSI Life Sciences, Yellow Springs, OH), Ocean Optics spectrometer model # 
CHEM2000-UV-VIS (Ocean Optics, Inc., Dunedin, FL), and JDS Uniphase Neon Laser
model # 1674MP (JDS Uniphase Corporation, San Jose, CA).
Solutions and Chemicals
TSM buffer, YSI-2357 buffer (YSI Life Sciences, Yellow Springs, OH), 
Sephadex G-75 resin, rose Bengal dye, and dextran-charcoal. The chemicals were 
purchased from Sigma-Aldrich Chemical Company (Sigma-Aldrich Corp., St. Louis,
MO) unless otherwise indicated. All solutions are made in deionized water unless noted
otherwise.
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TSM buffer contains 0.05OM trishydroxymethylaminomethane (tris base), 0.25 M 
sucrose, and 3.00 mM 2-mercaptoethanol (pH 7.5). It was the buffer used during all
experiments unless otherwise indicated. It was made in 1 L deionized water as follows:
6.05 g Tris base, 85.5g sucrose and 0.30 ml mercaptoethanol is weighed and added to 750 
ml cold deionized water (di-water) and are stirred until they dissolve. The pH of the 
solution is measured and is neutralized to pH 7.6, and then 250 ml of di-water is added. 
The solution is stirred in a cold box until it is cold, and the pH is checked again and 
restandardized if necessary ’ . Sephadex G-75 polymer (Amersham Biosciences,
Piscataway, NJ) was used to separate FABP from other proteins in cytosol by column 
chromato graphy3 ’4.
40.0 mM rose Bengal solution was prepared by mixing 41 milligrams of rose
Bengal in one liter of deionized water for the regular assay used in the In House Method 
(IHM3,4). The IHM uses 0.30 mL of 40 mM (~11 mM) rose Bengal solution for the assay. 
10 mM rose Bengal per liter was prepared in deionized water for the direct assay method. 
Rose Bengal for the direct assay is made in YSI-2357 buffer. 13 milligrams YSI-2357 
buffer per liter dissolved in deionized water. The use of the dye in all assay methods will 
be described in the second section of this chapter.
Dextran-coated charcoal was prepared by diluting 0.828 g of Na2HPO4 (Fisher 
Scientific Co., Pittsburgh, PA) with 200 mL of cold (4°C) deionized water and 
standardized to a pH of 7.4. Then, 1.0 g of Dextran T-170 (Fisher Scientific Co., 
Pittsburgh, PA) and 10.0 grams of Norit A decolorizing carbon (Fisher Scientific Co.,
Pittsburgh, PA) were added to the solution. Dextran-coated charcoal was used to remove
rose Bengal dye which did not bind the protein.
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All rats used in these studies were either purchased from Harlan-Sprague Dawley
(Indianapolis, IN), or bred from animals purchased from Harlan-Sprague Dawley. The 
strains used were spontaneously hypertensive rats (SHRs) and Holtzman rats. The
breeding and housing of all rats was in the University of Dayton animal facility. Strain 
differences, diets, and drugs including clofibrate (Ayerst Laboratories, Collegeville, PA),
and fenofibrate (Abbott Laboratories, North Chicago, IL) were used as described
elsewhere ’ to cause the variations of FABP levels denoted in the results section of this
thesis.
3.2 Routine In-House Method
Sacrificing the Animals and Preparing Cytosol 
In this method, devised and refined over ten years in our laboratory3’4, all animals
used were killed by decapitation after their weights were recorded. Then, their livers were
removed, and placed on ice. After weighing each liver, about 4 grams representative
samples were collected. Each sample was homogenized in a glass tube (Potter-Elvhjem 
homogenizer Bellco Glass, Inc., Vineland, NJ) with 1 mL of TSM buffer per gram of 
tissue3’4. Each homogenate was next poured into a centrifuge tube, placed in a Beckman 
fixed-angle 40-centrifuge rotor (Beckman Coulter, Inc., Palo Alto, CA) and centrifuged 
(105,000 x g) for 60 minutes at 2° C. After each centrifugation, the supernatant (cytosol) 
was separated from the sediment, and its volume was measured and recorded.
Sephadex G-75 Chromatography
A 1.25 x 70 cm column was prepared for use with each cytosol sample prior to 
each experiment ’ . The cytosol from one liver sample was pipetted into the top of the
column; the column was run until the sample (cytosol) entered the polymer matrix. 6 ml
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of TSM was added to the column, and a TSM drip was applied to elute the column. A 
fraction collector collected sixty aliquots of 1.5 mL (fractions) over 2 to3 hours. All the
proteins are eluted at different times and into different fractions. The tubes were then
assayed to check protein content and LFABP.
FABP Measurement
The fractions collected were subjected to three assays for quantitation. These were
the A-280 column assay for protein content, the A-560 column assay for the LFABP
content and the pool assay which quanitated tissue LFABP content. The A-280 and the
A-560 assays which utilized the fractions collected from G-75 columns will be called
Reference Assays to differentiate them from the pool assay which uses pooled column 
fractions shown to contain FABP by the A-560 column assay.
Assay Methods
A-280 Reference Assay: 0.1 mL of sample was removed from chosen fractions
from the G-75 column. They were each mixed with 0.9 mL of ice cold TSM buffer in
separate test tubes and read in the Milton-Roy spectrophotometer at 280 nm. Absorbance 
readings were graphed against fraction numbers as shown in Figure 1. The resultant large 
peak on the graph represents the majority of non-FABP proteins. The FABPs, which 
elute near the end of the chromatogram due to their small size, are found along the
downward slope of the curve.
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Figure 1: 280 nm absorbance from A-280 assay
A-560 Reference Assay: This assay uses the same samples from the column 
fractions as the 280 assay. First, 0.1 mL of each sample is mixed with 0.75 mL TSM and 
0.3 mL of 40 mM rose Bengal. The mixture was allowed to sit on ice for five minutes. 
Then, 0.15 mL of Dextran-charcoal was added and the mixture was kept on ice for eight 
minutes. Next, the samples were centrifuged in Centra-B Plus centrifuge for eight 
minutes, and finally the absorbance was measured and graphed as shown in Figure 2. 
After graphing the absorbance of 280 nm and 560 nm assays, the results were analyzed. 
The 280 nm peak confirmed that there are proteins present. The first 560 nm assay peak 
identifies most cell proteins. The second 560 nm peak shows which fractions contain 
FABP. The graph is plotted for two different Y-axis because they are read at different
wavelengths and show different absorbance.
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Figure 2: A-560 assay indicating the fractions containing FABP
Pool Assay (Reference): The fractions that contained FABP were pooled. Five 
samples of the pool were then diluted with TSM for assay as shown in Table 1 3’4.
Table 1: Pool Assay to quantitate FABP by IHM
Tube
Number
0 1 2 3 4 5
FABP pool 
(ml)
0.000 0.050 0.100 0.200 0.400 0.600
TSM (ml) 0.750 0.700 0.650 0.550 0.450 0.350
Six tubes were filled as shown. Following TSM addition, rose Bengal was added 
to each tube, the tubes were vortexed and allowed to stand on ice for 5 minutes, and
Dextran charcoal was added. The mixtures were kept on ice for eight more minutes and 
centrifuged in the Centra-B Plus centrifuge for eight minutes. The supernatants were 
drawn off and read at 560 nm3,4.
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3.3 Calculations
A series of calculations were used to obtain the amount of FABP in milligrams 
per gram liver. First, the absorbance read for the pool assay was divided by the volume of 
the pool to obtain absorbance per milliliter.
... . T . Absorbance 560Absorbance / mL pool =---------------------------
Pool volume in sample
Then the readings were averaged, and the total absorbance in the pool (in red 
binding units, RBU) was calculated by multiplying the average by 0.67, a factor devised 
to correct for changes in assay volumes in 1997 in our laboratory3,4.
Total RBU _ (average RBU/mL) X (Pool Volume) 
°3 0.67
The milligrams of FABP per gram tissue was calculated by dividing the total red 
binding protein units by 3.69 (the product of assay correction factor 2.86 and 1.29, the 
absorption of 1 mg pure LFABP in the assay3,4) and the weight of the tissue 
chromatographed.
mg FABP/g liver = Total RBU
(3.69) X(corrected weight)
15
CHAPTER 4
DIRECT ASSAY METHOD
4.1 Experimental Setup for Direct Assay
The assay developed here uses cytosol directly. I am developing this assay in an
effort to replace the much slower, more complicated IHM. This assay uses the YSI-2700
Select Biochemistry Analyzer which is added to an Ocean Optics Spectrometer (model #
CHEM2000-UV-VIS). A JDS Uniphase Neon Laser (model # 1674MP) of wavelength
543.5 nm is used as a light source to produce the emission as shown in Figure 3.
▲
Computer which 
contains the ocean 
optics spectrometer 
connected to YSI- 
2700 through an 
optical cable.
Figure 3: Experimental setup for the direct assay
The YSI-2700 Select Biochemistry Analyzer consists of a sampling chamber (400 pL 
volume) and a sipper which injects the test solution into the chamber. The sipper injects 
25 pL of sample per injection. An optical cable is attached to the sampling chamber at 
right angles to the laser beam which is the light source and a quartz mirror is placed
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opposite to the optical cable so any light reflected away from the optical cable is 
redirected back to it to provide a strong signal. The optical cable is connected to the 
spectrophotometer. Initially the sampling chamber is flushed with 10 mM rose Bengal 
dye and the emission peak of the dye is recorded on the computer via the Ocean Optics 
software supplied with the spectrophotometer. The analyzer is designed to flush the 
chamber three times, every time the flush button is used. Next, cytosol is injected into 
the sampling chamber which contains rose Bengal dye and mixed quickly by the 
instrument. Liver FABP binds rose Bengal and the change in the emission peak is 
recorded by the software. The binding of LFABP and rose Bengal dye enhances the 
emission peak height. This process is repeated with several different samples of diluted 
cytosol (1:1, 1:3, 1:5, 1:8 and 1:10 dilutions), and the emission peak is recorded for each 
sample. All the samples are diluted in TSM buffer. The sampling chamber is flushed with 
rose Bengal dye before and after injecting the cytosol because the rose Bengal emission 
peak is used as a reference to record the change in emission for different dilutions of 
cytosol. The recorded emission peak is plotted on an Excel spreadsheet and the data are 
related and compared with the results obtained using the IHM.
4.2 Data Plotting and Calculations
The emission spectrum is recorded and stored on the computer using the Ocean 
Optics software. The recoded data can then be opened in an Excel spreadsheet. The data 
gives the wavelength from 178 nm to 879 nm and the respective intensity of the emission 
peak next to it as shown in the sample data below. The data are plotted using the XY 
(scatter) chart type. The emission peak of rose Bengal and the enhanced emission peak
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due to FABP binding are plotted. Then the highest point of both the emission peaks are 
recorded and the highest point of the enhanced emission peak is subtracted from the 
highest point of the rose Bengal emission peak which gives the actual effect, or effective 
peak height, due to the presence of FABP.
The same procedure is repeated for each concentration of FABP or cytosol used 
and then the concentration of FABP in the chamber is plotted against the effective peak 
height. It was seen that the concentration of FABP was proportional to the enhancement 
of the emission peak. The data are shown below in Table 3 and plotted in Figure 4.
Table 2: Sample emission peak data
Wavelength (nm) Intensity (counts)
178.4 0
228.7 0.90
278.5 -0.90
328.8 -1.4
378.0 0.10
428.7 1.3
478.8 2.9
528.9 7.4
578.8 331
628.8 123
678.5 16
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Table 3: FABP concentration against effective emission peak height
Dilution ratio [FABP] Enhanced 
Emission Peak
Rose Bengal 
Emission Peak
Effective peak 
Height
1:1 12.5 602 231 369
1:3 8.3 474 222 251
1:5 5.0 389 232 156
1:10 2.5 318 244 73
[FABP]
Figure 4: Effective emission peak plotted against the FABP concentration
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CHAPTER 5
Results
5.1 Rose Bengal
10 mM rose Bengal was made in YSI-2357 buffer, as explained in Material and 
Methods discussion. The rose Bengal solution was connected to a pump which allows the 
YSI-2700 Select Bioanalyzer to use it to flush the sampling chamber through a sipper.
The sampling chamber is flushed three times in between uses. The laser and the 
equipment are set as explained in Section 2.1. The emission peak of the rose Bengal 
solution in the sampling chamber is then recorded on the computer using Ocean Optics 
software. The recorded spectral data are then plotted in an Excel spread sheet. The 
intensity of the emission is then plotted against the wavelength (e.g. Figure 5).
Figure 5: Emission peak of 10 mM rose Bengal solution
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Different concentrations (10 mM, 20 mM, 50 mM and 100 mM) rose Bengal 
solutions were made in YSI-2357 buffer. These solutions were used to flush the sampling 
chamber as already explained. The solutions are used one after the other and the emission 
peak of each solution is recorded. The data are then stored and plotted in Excel. As 
shown in Figure 6, higher concentrations of rose Bengal gave smaller emission peaks 
since the solutions were hazy allowing less light to penetrate through to the optical cable. 
The results show that 10 mM rose Bengal solution is the optimum concentration to be
used in our direct assay method.
Figure 6: Different concentration of rose Bengal used to check the 
concentration which is optimum to use
Initially partial purified LFABP (9.5mg/ml) was used. The LFABP was purified 
at Dr. Singer’s laboratory using different chromatography columns [G-75, A-50 and 
DEAE-Sephadex A-50 ’ “]. The LFABP was stored in 500 pi aliquots to minimize 
FABP breakdown on repeated thawing and freezing. 10 mM rose Bengal solution is used 
to flush the sampling chamber and the emission spectrum is recorded. The LFABP 
(9.5mg/ml) is placed in the sample holder from which the sipper injects 25 pi samples 
into the sampling chamber. The injected LFABP is mixed with the rose Bengal solution
21
present in the sampling chamber by a magnetic stirrer. The LFABP binds with rose 
Bengal causing an enhancement in the rose Bengal emission peak. The enhanced 
emission peak is then recorded and plotted (e.g. Figure 7).
Figure 7: Enhanced emission peak due to binding of 9.5 mg/mL LFABP with 10 mM 
rose Bengal solution
Several different concentrations of LFABP (9.5mg/mL, 4.75mg/mL, 2.4mg/mL, 
0.95mg/mL, and 0.095mg/mL) were used, consecutively, in the direct assay. Initially 10 
mM rose Bengal solution was used to flush the chamber and then 9.5mg/mL LFABP was 
injected into the sampling chamber. The emission peak of rose Bengal and the enhanced 
emission peak due to LFABP binding with rose Bengal were recorded. The sampling 
chamber is always flushed with rose Bengal solution before and after injecting LFABP. 
The LFABP concentration cannot be diluted below 0.095mg/mL because at this level no 
change in the emission peak occurs. Figure 8 shows that the emission peak ratio, which is 
the difference between the emission peak height due to LFABP and rose Bengal divided
by the emission peak ratio of rose Bengal alone shows a linear profile for hLFABP.
Figure 8: Effect of different concentrations of LFABP on the emission peak of 
10 mM rose Bengal solution
„ . . , . Enhanced emission peak height due to LFABP- RB bindingAE, Emission peak ratio =----------------------- £-------- -----------------------------------—
Emission peak height of Rose Bengal alone
To check the specificity of the direct assay method, bovine serum albumin (BSA), 
myoglobin and hemoglobin were used in the processes described earlier for FABP. The 
serum albumin was used first. lOmM rose Bengal solution is used to flush the sampling 
chamber and the emission spectrum was recorded (Figure 9). Then BSA was placed in 
the sample holder from which the sipper injects 25 pL samples into the chamber. The 
BSA binds rose Bengal causing the emission peak to quench slightly, as shown in Figure 
9. The quenched emission peak is then recorded and plotted. Three different 
concentrations (0.1 mg/mL, 1 mg/mL and 10 mg/mL) of BSA were used as explained 
earlier with LFABP. As shown in Figure 9, 0.1 mg/mL BSA quenches the emission peak 
and 10 mg/mL BSA causes both peak shifting and quenching.
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Figure 9: Effect of O.lmg/mL BSA on the emission peak 10 mM rose Bengal
Figure 10: Effects of different concentrations of BSA on the emission peak of 
10 mM rose Bengal solution
The same process was repeated for myoglobin and hemoglobin. When 10 mg/ml 
myoglobin and hemoglobin was used it was seen that both quench the rose Bengal 
emission peak (Figures 11a and lib). The same results were seen with lower 
concentrations of myoglobin and hemoglobin. So, all three proteins quenched the 
emission peak whereas LFABP enhanced the emission peak.
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(a) (b)
Figure 11: Effect of 10 mg/ml Myoglobin (a) and Hemoglobin (b) on the emission peak of 
10 mM rose Bengal
Next, effects of BSA, myoglobin, and hemoglobin on the enhanced emission due 
to presence of LFABP were tested. Initially, 9.5 mg/mL LFABP was injected into the 
sampling chamber with help of the sipper and the enhanced emission peak was recorded. 
Then we compared this data to those with mixtures of the LFABP and BSA (0.1 mg/ml, 1 
mg/ml, and 10 mg/ml). BSA had very little effect on the enhanced emission peak of 
LFABP (Figure 12).
Figure 12: Effect of different concentrations of BSA on the enhanced 
emission peak of 10 mM rose Bengal
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The same process was repeated to see the effect of different concentrations of 
LFABP on the quenched emission peak due to binding of 0.1 mg/mL and 10 mg/mL BSA 
with rose Bengal. The results were recorded and plotted as shown in Figure 13. The 
figure shows that the presence of 0.1 mg/mL BSA does not cause any effect of the 
enhancement of emission peak due to the binding of LFABP with the dye.
Figure 13: Effect of different concentrations of FABP on the quenched 
emission peak using 0.1 mg/mL BSA
The process was repeated for lmg/mL and 10 mg/mL BSA with different 
concentrations of LFABP. The quenched emission peak due to binding of rose Bengal 
dye with 1 mg/mL BSA is used as a control between the different concentrations of
LFABP and similarly for 10 mg/mL BSA. The control is the reference peak. The
presence of 1 mg/mL and 10 mg/mL BSA did not affect the enhancement of the emission
peak as shown for 10 mg/ml BSA in Figure 14.
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Figure 14: Effect of different concentrations of FABP on the quenched 
emission peak due to 10 mg/mL BSA
The process was also repeated with myoglobin and hemoglobin to see their effects 
on the emission peak of rose Bengal. Once again 0.1 mg/ml, 1 mg/ml, and 10 mg/ml 
samples of myoglobin and hemoglobin were compared. As shown in Figures 15 and 16, 
myoglobin had no effect on LFABP binding to rose Bengal; LFABP enhanced the 
emission peak normally in the presence of myoglobin.
Figure 15: Effect of 10 mg/ml myoglobin on the enhanced emission peak 
by 9.5 mg/ml LFABP
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Figure 16: Effect of 9.5 mg/ml LFABP on the quenched emission peak by 
10 mg/ml. myoglobin
The experiments shown in Figure 15 and 16 are done one after the other in a short
period of time. The LFABP preparation used in both experiments was the same and the 
emissions can be compared. The heights of the enhanced emission peak caused by 
LFABP were found to be similar in both cases. The same result was seen in Figure 17 
when the process was repeated for hemoglobin.
Figure 17: Effect of 9.5 mg/ml LFABP on the quenched emission peak due to 
10 mg/mL hemoglobin
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Table 4: Sample calculation of [FABP] from the graph for myoglobin
FABP concentration 
used
Emission peak 
ratio for 
Myoglobin
FABP concentration 
calculated from the 
graph
9.5 mg/ml 3.08 9.2 mg/ml
4.75 mg/ml 1.87 4.42 mg/ml
2.375 mg/ml 1.33 2.31 mg/ml
The data of Figures 9 through 17 qualitatively illustrate that the direct assay 
method is specific to LFABP, and is not strongly influenced by the presence of other 
similar potentially interfering species. The data of these figures can also be investigated 
quantitatively using the relation between emission peak ratio and LFABP of Figure 8. 
Table 4 compares the known LFABP concentrations with those calculated using 
measured emission peak ratios in the presence of myoglobin and the relation between this 
parameter and LFABP concentration shown in Figure 8. As this comparison indicates, the 
direct assay method provides reasonable estimate of the LFABP concentration.
Next, the samples collected from the column chromatography in our IHM were 
used in our direct assay method. As explained previously IHM produces 60 samples of 
cytosol eluted from the column. The A-560 assay indicated the tubes which contain the
FABP and tubes that lack FABP as shown in Figure 18. The tubes which contain FABP 
and which lack FABP are pooled separately and are used in the direct assay method one 
after the other. The YSI-2700 Select Biochemistry Analyzer was then used to study the 
emission peak produced by interaction of rose Bengal with LFABP.
It was seen that the FABP in “FABP pool” detected by IHM caused enhanced 
emission peak, while the non-FABP containing pool did not enhance the peak (Figure
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19). Since the pool collected from the Sephadex Cr-75 column tubes was dilute, we 
concentrated it by 8 fold using an Amicon stirred cell model # 8400 before using it in the 
direct assay. The pool lacking FABP contained most other proteins (e.g. serum albumin 
and hemoglobin). Myoglobin was present in the pooled FABP-containing fractions.
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Figure 19: Effect of FABP and non-FABP containing pool on the emission peak 
of rose Bengal
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In the final step to quantitate LFABP by the direct assay method, cytosol was 
used directly. The previous experiments had shown that the direct assay method was 
specific for FABP and once the specificity of the assay was clear cytosol was tested in the 
direct assay. Cytosol was prepared as explained in Section 1.2. When injected into the 
analyzer the LFABP present binds with rose Bengal present in the sampling chamber 
causing enhancement in its emission peak (Figure 20). The magnitude of enhancement 
depends upon the amount of FABP present in the tissue. Previous research conducted in
"5 1 9 I
our laboratory ’ and by others’ showed that animals on special diets like clofiberate and 
fenofibrate will have higher amounts of FABP in there tissue hence causing larger
enhancement (Figure 21).
Wavelength (nm)
Figure 20: Effect of cytosol on the emission peak of 10 mM rose Bengal
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Figure 21: Enhanced emission peak of cytosol from animals on different diets
All the animals which were on special diets and the control animals were plotted 
against the data take by the IHM. The IHM gives the amount of FABP present per gram 
tissue. Figure 21 shows that animals on special diets which have higher amounts of 
FABP showed higher effective peak heights and they grouped together while the control 
animals which had lower amounts of FABP formed a second group at lower levels.
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Figure 22: IHM data (mg FABP/g tissue) plotted against the effective emission peak 
height of the direct assay method
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5.2 Calculations
The effective peak height was calculated as explained in Chapter 2 where the 
enhanced emission peak data was separated from the emission peak of rose Bengal to get 
the effective emission peak due to the presence of LFABP. The effective emission peak 
of LFABP is then multiplied with the dilution ratio and calculated for ImL solution by 
multiplying it with 40 since only 25/xL of sample was injected into the sampling
chamber.
Table 5: Effective emission peak height calculated for ImL sample
Dilution ratio Effective peak height Effective peak height for ImL
sample
1:2 396.94 396.64x2x40 =31755
1:3 251.89 251.89x 3 x40 = 30226
1:5 156.64 156.64x 5 x40 = 31328
1:10 73.94 73.94x10x40 = 29576
As shown in Table 5 effective peak heights are calculated for different animals. 
The effective peak height is then plotted against the IHM data. Table 6 shows the 
comparison between the IHM (mg FABP/g tissue) data and the effective peak height 
calculated. The data in Table 6 is plotted in Figure 22.
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Table 6: Comparison of IHM with direct assay method
IHM
(mg FABP/g) 
data
Effective peak height 
for
1 mL sample
0.92 12745
1.02 15240
1.02 17423
1.02 17884
1.02 20867
1.24 19000
1.28 19977
1.29 20307
1.38 21267
2.31 34971
2.31 34537
2.36 35170
2.45 36235
2.46 38176
2.85 39481
2.88 41200
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CHAPTER 6
DISCUSSION
The present study focuses on developing a new assay for measuring fatty acid 
binding proteins directly from cytosol. The new method uses the spectrochemical 
perturbation that is caused by the binding of LFABP to rose Bengal dye for direct 
measurement of LFABP. The previous research conducted by others6 and our own 
IHM3,4 used spectroscopic and binding properties of FABP for identifying and measuring 
fatty acid binding proteins in cytosol. In the previous research conducted by others and 
our own IHM, the FABP is subjected to chromatography on a Sephadex G-75 
equilibrated with buffer. Elution fractions containing FABP are assayed for radioactivity6 
and absorbance at 280 nm3, 6 and 560 nm3, 4. Two major peaks are obtained, the second 
corresponding to FABP. These methods are complex and labor intensive.
The results of the present study in developing the new assay method aimed to 
make the process simple, while obtaining similar results. The new direct assay method 
has been tested for specificity for homogenous LFABP3, 4 (hLFABP) and LFABP in 
presence of other proteins (non-homogenous). Homogenous LFABP was obtained by 
Thomas Burnett in our laboratory3, 4 by applying cytosol to different chromatography 
columns (G-75, A-50, and DEAE-Sephadex A-503,4).
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The non-homogenous LFABP is found in cytosol which contains other potential 
contaminants3 along with FABP. As shown Figure 7, homogenous LFABP interacts with 
rose Bengal dye causing an enhancement in its emission peak. When different
concentrations of hLFABP were used, it was seen (Figure 8) that the response curve was
linear and the new method was able to detect hLFABP within a concentration range from 
9.5mg/mL to 0.095mg/mL as evidenced by the change in the enhancement of the 
emission peak of rose Bengal. This figure shows that the direct assay method is sensitive 
enough to measure FABPs at low concentrations typical of those in the physiological
range.
The direct assay method also shows (Figures 10, 11) that different proteins such
as bovine serum albumin, myoglobin, and hemoglobin do not fluoresce and bind to rose 
Bengal, quenching its emission peak. A number of proteins which bind fatty acids and 
other organic anions are present in the cytosol out of which serum albumin, myoglobin 
and hemoglobin have nucleotide sequence homologies with FABP and have similar 
binding properties. Serum albumin is the most abundant protein in the circulatory system 
and makes up a large percentage of protein in cytosol. These proteins which are 
components of cytosol and their presence may interfere with the assay to quantitate
LFABP if the assay is not specific, as they can interfere with the IHM unless the G-75
chromatogram is carried out. This result shows that these proteins which are components
of cytosol do not cause the same effect as FABP on the emission peak of rose Bengal by
the direct assay method.
The specificity of the assay was determined from results in Figures 14 through 17
which show that the presence of other potential contaminants of cytosol like myoglobin,
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serum albumin, and hemoglobin do not interfere or alter the data taken with hLFABP.
Initially these proteins were tested against the enhanced emission peak of rose Bengal 
due to the presence of LFABP, and it was seen that the other proteins had very little 
effect on the enhanced emission peak (Figures 12, 15, and 17). Next, LFABP effect on
the quenched emission peak due the presence of proteins like serum albumin, myoglobin, 
and hemoglobin was tested. It was seen that the LFABP enhanced the quenched emission 
peak normally. These results show that our assay is specific for LFABP.
In the IHM3’ 4 the chromatogram collected from the Sephadex G-75 column 
shows (Figure 18) two major emission peaks for the A-560 reference assay. As explained 
in Section 1.2 the Sephadex G-75 polymer matrix separates proteins on the basis of 
molecular size. The proteins which are of higher molecular size such as serum albumin 
and hemoglobin pass around the matrix covering lesser column volume, eluting earlier 
than the smaller molecular size proteins such as myoglobin and FABP which elute later2. 
The A-560 reference assay uses the relationship between molecular size and elution 
behavior of proteins to identify most cell proteins. The first emission peak of the A-560 
reference assay corresponds to a molecular mass greater then 60 kDa6 and may reflect the 
presence of serum albumin6 and other proteins with fatty acid-binding activity6. The 
second peak contains LFABP (Figure 18).
Both the FABP and non-FABP containing samples, as indicated from the 
emission peaks of A-560 assay, were pooled and used in the direct assay method. It was 
seen (Figure 19) that the pool from the second peak enhanced the emission peak of rose 
Bengal indicating the presence of LFABP, while the pool from the first peak did not 
enhance the emission peak but shifted it. This indicated the presence of proteins such as
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serum albumin and other potential contaminants of cytosol.
In the final step to quantitate LFABP from cytosol, this cell fraction was directly 
used in the direct assay method as shown in Figure 20. It was seen that the cytosol 
enhanced the emission peak of rose Bengal; and on the basis of the previous results 
(Figures 14 through 17), it was certain that the enhancement caused by the cytosol was 
due the presence of FABP. Previous results also show (Figure 19) that the enhancement 
of the rose Bengal emission peak is only due to the presence of FABP, while the other 
proteins do not enhance the emission peak.
Research conducted previously in our laboratory3, 4 and by others21 showed that 
rats on special diets such as clofibrate and fenofibrate show high levels of LFABP 
compared with the animals on the normal diet. The cytosol from the animals on special 
diets and the normal diet was used in the direct assay method. It was seen (Figure 21) that 
the animals on the special diet had larger enhancement of emission peak indicating the 
presence of high levels of LFABP, while animals on normal diet had relatively smaller 
enhancement of emission peak indicating lower levels of LFABP. This result agrees with 
the previous research conducted in our laboratory3,4 and by others21.
In the final stage of my effort to develop this new assay the results from the IHM 
were compared to and plotted against the effective peak height due to the presence of 
LFABP. The pool assay in the IHM gives the amount of LFABP present per gram of 
tissue (Liver) which was plotted against the effective peak height, showing (Figure 22) 
that both are directly proportional to each other. It was seen that the data from the IHM 
which has higher amount of LFABP present per gram of tissue had higher effective peak 
heights while the animals which had lower amount of FABP showed lower effective peak
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heights. All animals on special diets formed a group higher than the control animals 
which formed a second lower group. The results plotted in Figure 22 demonstrate the
relation between the direct assay method and the IHM. If we get similar results in both 
the methods then the data from IHM (i.e. mg FABP/g tissue) should be directly 
proportional to the effective emission peak in the direct assay method, which means 
linear data. Some points in the study show variation from linearity, which means that 
similar results were not always obtained for the direct assay method and the IHM.
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CHAPTER 7
CONCLUSION AND RECOMMENDATIONS
The direct assay method, when perfected, will facilitate uncovering FABP roles in 
health and disease, improving treatment of lipid related human diseases. This process will 
add to our ability to study FABPs and can be used to study IFABP further. These studies, 
in the future may extended to make biosensors to detect fatty acid binding proteins. The 
direct assay method is 10 times faster than the IHM and uses less tissue. The new direct
assay method can be applied to beef liver FABP to see if similar results are obtained.
While the direct assay method is promising, it will need future work to perfect it. 
It is recommended that direct assay method can be improved by using a 
spectrophotometer to replace our present experimental setup. It is also suggested that 
larger sample size of cytosol or LFABP may decrease the error see in the result where the 
data for the direct assay method is compared with the IHM. The direct assay method can 
be future be improved by understanding the stoichiometry of the reaction taking place 
between the FABP and rose Bengal dye. The use of sol-gel slides will help in 
understanding the interactions between the rose Bengal and FABP better if the solution 
can be kept cold for long periods of time.
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